News
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ('Kelun-Biotech', 6990.HK) today announced that results from its ...
SINGAPORE—China is racing toward economic self-sufficiency by weaning itself off American technology. But it has made a ...
CURE spoke with the principal investigator of a clinical trial evaluating a therapeutic vaccine for patients with advanced ...
US drug companies are increasingly licensing experimental medicines invented by Chinese firms. The recent deals could be ...
When journalist Jon Gluck learned he had multiple myeloma, doctors told him he had 18 months to live. That was 20 years ago. ...
At the crossroads of innovation and equity, Josette Gbemudu and Merck are helping rewrite the narrative for breast cancer ...
21h
Zacks Investment Research on MSNBMY Collaborates for Oncology Drug: Will This Boost Its Portfolio?Bristol Myers Squibb BMY recently announced a strategic collaboration agreement with BioNTech BNTX for the global ...
Merck, as it prepares a new version of its cancer blockbuster Keytruda, gets a boost in its patent dispute with Halozyme ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results